The political aftermath of the latest elections raises critical questions regarding federal drug pricing policies and the future leadership direction of the Food and Drug Administration. Simultaneously, investigative reporting reveals concerning practices within international reproductive healthcare, where vulnerable patients seek unverified solutions. Reporter Megan Molteni found that women are actively traveling to overseas fertility clinics that market an expensive, questionable genetic procedure.
Key points
Federal drug pricing policy faces potential shifts following the recent midterm political…: Federal drug pricing policy faces potential shifts following the recent midterm political victories by Democrats.
Oversight questions surround the Food and Drug Administration as new legislative dynamics…: Oversight questions surround the Food and Drug Administration as new legislative dynamics take shape in Washington.
Overseas fertility clinics are attracting international patients by marketing costly gene…: Overseas fertility clinics are attracting international patients by marketing costly genetic treatments that lack established credibility.
Sources checked by our analysis pipeline: 1
How will the midterm results affect drug pricing policy? What is the fate of the Food and Drug Administration? And why are women traveling to fertility clinics abroad?
On this week’s episode of “The Readout LOUD,” STAT’s biotech podcast, we bring on our Washington correspondent Daniel Payne to chat about the massive midterm victory for Democrats and what it means for health and medicine.
We also bring on our colleague Megan Molteni to discuss her investigation into a network of clinics that have advertised fertility success with a questionable and expensive genetic procedure.
For more on the midterm implications, go here; and for more on the fertility procedure, go here.
Be sure to sign up for “The Readout LOUD” on Apple Podcasts, Spotify, or wherever you get your podcasts.
Medical researchers created the miniature robotic platform to support surgeons during high-precision back operations requiring tiny incisions. By reducing the physical footprint of surgical instruments down to the millimeter scale, the project focuses on advancing minimally invasive procedural techniques. The institution has yet to reveal comprehensive technical data or a rollout timeline for hospital deployment.
Public health officials are targeting products containing more than 150mg of caffeine per litre due to clear evidence linking them to sleep disruption, physical aches, and mental health challenges. This regulatory push aligns the nation with forthcoming retail restrictions across the border. However, industry representatives argue that the restriction is unsupported by sufficient proof of widespread harm.
Health officials are facing a critical evaluation following a rare fatal pediatric case in the state. Experts plan to convene in the coming days to review the broader epidemiological implications of the incident. Their primary focus will be assessing whether the country has officially lost its national disease elimination status.